Related Experiment Video
Updated: Jun 28, 2025

07:23
An Optimized Protocol for the Efficient Radiolabeling of Gold Nanoparticles by Using a 125I-labeled Azide Prosthetic Group
Published on: October 10, 2016
8.2K
211At on gold nanoparticles for targeted radionuclide therapy application
Jeffrey Tanudji1, Hideaki Kasai2, Michio Okada2,3
1Department of Applied Physics, The University of Osaka, 2-1 Yamadaoka, Suita, Osaka 565-0871, Japan.
Physical Chemistry Chemical Physics : PCCP
|April 17, 2024
Summary
Targeted alpha therapy (TAT) uses radioactive elements to destroy cancer cells. Gold nanoparticles (AuNPs) show promise as carriers for these radionuclides in developing effective cancer treatments.
Area of Science:
- Nuclear medicine
- Nanotechnology
- Oncology
Background:
- Targeted alpha therapy (TAT) utilizes alpha particle decay from radionuclides for cancer treatment.
- This method aims to maximize cancer cell damage while sparing healthy tissues.
- Gold nanoparticles (AuNPs) are explored as carriers for radionuclides in TAT.
Purpose of the Study:
- To review the current developments and technological state of AuNP-based TAT.
- To identify challenges in theoretical, experimental, and applied aspects of AuNP-mediated TAT.
- To encourage further research and collaboration in the field of targeted alpha therapy.
Main Methods:
- Review of existing literature on targeted alpha therapy and gold nanoparticles.
- Analysis of radionuclide adsorption onto gold surfaces, specifically astatine and iodine.
- Discussion of AuNP functionalization with targeting ligands and other therapeutic agents.
Main Results:
- Astatine and iodine demonstrate stable adsorption onto gold surfaces.
- AuNPs offer versatile platforms for radionuclide delivery and targeted cancer therapy.
- Significant theoretical and experimental challenges remain for clinical translation.
Conclusions:
- AuNP-based targeted alpha therapy presents a promising avenue for cancer treatment.
- Further research is crucial to overcome existing challenges and advance clinical applications.
- Increased collaboration can accelerate progress and societal impact in this field.

